BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12781045)

  • 1. A risk of malignancy index in preoperative diagnosis of ovarian cancer.
    Ma S; Shen K; Lang J
    Chin Med J (Engl); 2003 Mar; 116(3):396-9. PubMed ID: 12781045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer].
    Ma S; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):162-4. PubMed ID: 11783394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.
    Tingulstad S; Hagen B; Skjeldestad FE; Onsrud M; Kiserud T; Halvorsen T; Nustad K
    Br J Obstet Gynaecol; 1996 Aug; 103(8):826-31. PubMed ID: 8760716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two malignancy risk indices based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses.
    Morgante G; la Marca A; Ditto A; De Leo V
    Br J Obstet Gynaecol; 1999 Jun; 106(6):524-7. PubMed ID: 10426607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.
    Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T
    Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
    Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
    Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
    Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of malignancy index in preoperative evaluation of pelvic masses.
    Ashrafgangooei T; Rezaeezadeh M
    Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three risk of malignancy indices in evaluation of pelvic masses.
    Manjunath AP; Pratapkumar ; Sujatha K; Vani R
    Gynecol Oncol; 2001 May; 81(2):225-9. PubMed ID: 11330953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignancy index in the preoperative evaluation of pelvic masses.
    Obeidat BR; Amarin ZO; Latimer JA; Crawford RA
    Int J Gynaecol Obstet; 2004 Jun; 85(3):255-8. PubMed ID: 15145261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
    Moolthiya W; Yuenyao P
    Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of malignancy index in discrimination of adnexal masses.
    Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
    Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
    Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
    Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases?
    Bailey J; Tailor A; Naik R; Lopes A; Godfrey K; Hatem HM; Monaghan J
    Int J Gynecol Cancer; 2006; 16 Suppl 1():30-4. PubMed ID: 16515564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative evaluation of ovarian mass: risk of malignancy index.
    Asif N; Sattar A; Dawood MM; Rafi T; Aamir M; Anwar M
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):128-31. PubMed ID: 15228841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
    Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
    Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive values of the ultrasound parameters, CA-125 and risk of malignancy index in patients with ovarian cancer.
    Antovska SV; Bashevska N; Aleksioska N
    Klin Onkol; 2011; 24(6):435-42. PubMed ID: 22257232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound.
    Arun-Muthuvel V; Jaya V
    Asian Pac J Cancer Prev; 2014; 15(6):2929-32. PubMed ID: 24761927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.